George Vlasuk/X
Nov 6, 2026, 04:28
George Vlasuk: A New LMWH Without the Risk of HIT?
George Vlasuk, Technical Consultant at Navitor Pharmaceuticals, shared a post on X about a recent article by Jian-Qun Deng et al., published in Science Translational Medicine, adding:
“Really, a new LMWH? – A synthetic heparin oligosaccharide decouples anticoagulation from heparin-induced thrombocytopenia risk.”
Title: A synthetic heparin oligosaccharide decouples anticoagulation from heparin-induced thrombocytopenia risk
Authors: Jian-Qun Deng, Xian-Xian Duan, Yu-Han Zhao, Yi Li, Ya-Lin Cao, Xin-Yu Li, Chao-Yue Li, Wen-Jie Jiang, Feng Xu, Ju-Zheng Sheng
Stay updated with Hemostasis Today.
-
Nov 6, 2026, 04:16Thirunavukkarasu Angappan: Hemophilia Care Gap – What Plasma Fractionation Can and Cannot Fix
-
Nov 6, 2026, 04:15Lucio D’Anna: When to Resume FAfter Haemorrhagic Transformation
-
Nov 6, 2026, 04:10Early Pregnancy DOAC Exposure Shows No Increased Birth Defect Risk – JTH
-
Nov 6, 2026, 03:05Luke McLaughlin: Every Voice Counts in the Global Hemophilia Community
-
Nov 6, 2026, 02:51Chokri Ben Lamine: 2026 ASH Abstract Achievement Award Recognition
-
Nov 6, 2026, 02:42Samin Mohsenian: Understanding Bleeding Disorder of Unknown Cause
-
Nov 6, 2026, 02:22Platelet SYK Signaling and Cancer Metastasis – JTH
-
Nov 6, 2026, 02:09Shadi Tabibian: November 2026 Hemophilia and Bleeding Disorders Bulletin
-
Nov 5, 2026, 19:17Cedric Hermans: New HAVEN 6 Publication Highlights Emicizumab Outcomes in Mild and Moderate Haemophilia A